Scrip Asks…What Does 2023 Hold For Biopharma? Part 6: Artificial Intelligence
Transforming Big Data Into Meaningful Outcomes For Health
The biopharma industry may not have been the fastest adopter of artificial intelligence, but its vast potential means companies of every shape and size know they cannot ignore it. Executives, advisors and investors share their predictions around the impact of AI in 2023.
